Prosecution Insights
Last updated: November 20, 2026

Casey Shea Hagopian, USPTO Patent Examiner

Listed by the USPTO as HAGOPIAN, CASEY SHEA

Tech Center 1600 • Art Units: 1611 1615 1616 1617

This examiner grants 54% of resolved cases

Analysis

HAGOPIAN, CASEY SHEA is a USPTO patent examiner in Tech Center 1600 and Art Unit 1611. The profile covers 574 resolved cases, with an allowance rate of 54.2% and a median of 1218 days to allowance. The interview lift of 33.8% indicates that interviews are associated with a meaningful improvement in allowance outcomes within this resolved-case record.

The portfolio includes 3M Company, The Regents of the University of California, and Globus Medical Inc. Representative firms are Knobbe, Martens, Olson & Bear, LLP, Norton Rose Fulbright US LLP, and SUGHRUE MION, PLLC. Practitioners handling matters in this docket can use the profile to anticipate a moderate allowance environment and to evaluate whether interview preparation should be part of prosecution planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.2%
Allow Rate
-5.8% vs TC avg
644
Total Applications
+33.8%
Interview Lift
1218
Avg Prosecution Days
Based on 574 resolved cases, 2023–2026

Rejection Statute Breakdown

2.1%
§101 Eligibility
12.3%
§102 Novelty
42.1%
§103 Obviousness
28.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17671071 ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR Final Rejection The Regents of the University of California
18046281 Thermoresponsive or Shear-Thinning Injectable Gel Compositions for Treatment of Arthritis Final Rejection GLOBUS MEDICAL, INC.
19119944 ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM Non-Final OA Solventum Intellectual Properties Company
18870174 ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM Non-Final OA Solventum Intellectual Properties Company
18875297 ORAL CARE COMPOSITION COMPRISING A PEROXIDE AND AN ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK COPOLYMER Non-Final OA BASF SE
18286541 BIOCHEMICAL ACTIVATION OF DYSFUNCTIONAL SKELETAL STEM CELLS FOR SKELETAL REGENERATION Final Rejection The Board of Trustees of the Leland Stanford Junior University
18660711 Silicone-Free Hair Conditioner Non-Final OA Henkel AG & Co. KGaA
18120726 USE OF THERMOLYSIN TO REDUCE OR ELIMINATE BACTERIAL BIOFILMS FROM SURFACES Final Rejection SMITH & NEPHEW, INC.
18995446 HYALURONIC ACID DERIVATIVE PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
19045529 ENDOSCOPE VISUAL FIELD-SECURING VISCOELASTIC COMPOSITION Non-Final OA Otsuka Pharmaceutical Factory, Inc.
18860152 Makeup Composition Comprising a Polyphenol, a Polyoxyalkylenated or Polyglycerolated Compound, a Monoalcohol and an Acid, and Method Employing Same Non-Final OA L'OREAL
18721360 METHOD OF FORMING A READY-TO-USE AGRICULTURAL COMPOSITION COMPRISING GLUFOSINATE Non-Final OA NOURYON CHEMICALS INTERNATIONAL B.V.
17753790 HIGH LOAD FORMULATION CONTAINING A SULFOPOLYMER Non-Final OA Eastman Chemical Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Casey Shea Hagopian's allowance rate?

54.2% of resolved applications examined by Casey Shea Hagopian were allowed (574 resolved cases), compared with 35.4% across Art Unit 1611 over the last five years.

Does an interview help with examiner Casey Shea Hagopian?

This examiner's interview lift is +33.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Casey Shea Hagopian take to allow a patent?

Applications allowed by Casey Shea Hagopian took 1,218 days on average from filing to allowance.

Which art unit does examiner Casey Shea Hagopian work in?

Casey Shea Hagopian examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month